These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 15925417

  • 21. Biological features (inflammation and neoangiogenesis) and atherosclerotic risk factors in carotid plaques and calcified aortic valve stenosis: two different sites of the same disease?
    Mazzone A, Epistolato MC, Gianetti J, Castagnini M, Sassi C, Ceravolo R, Bevilacqua S, Glauber M, Biagini A, Tanganelli P.
    Am J Clin Pathol; 2006 Oct; 126(4):494-502. PubMed ID: 16938654
    [Abstract] [Full Text] [Related]

  • 22. VAP-1, Eotaxin3 and MIG as potential atherosclerotic triggers of severe calcified and stenotic human aortic valves: effects of statins.
    Anger T, Pohle FK, Kandler L, Barthel T, Ensminger SM, Fischlein T, Weyand M, Stumpf C, Daniel WG, Garlichs CD.
    Exp Mol Pathol; 2007 Dec; 83(3):435-42. PubMed ID: 17490641
    [Abstract] [Full Text] [Related]

  • 23. Transcription factor Egr-1 in calcific aortic valve disease.
    Ghazvini-Boroujerdi M, Clark J, Narula N, Palmatory E, Connolly JM, DeFelice S, Xu J, Jian B, Hazelwood S, Levy RJ.
    J Heart Valve Dis; 2004 Nov; 13(6):894-903. PubMed ID: 15597579
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis.
    Peltonen TO, Taskinen P, Soini Y, Rysä J, Ronkainen J, Ohtonen P, Satta J, Juvonen T, Ruskoaho H, Leskinen H.
    Circulation; 2007 Sep 11; 116(11):1283-9. PubMed ID: 17709640
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
    Yeghiazaryan K, Skowasch D, Bauriedel G, Schild H, Golubnitschaja O.
    Amino Acids; 2007 Jan 11; 32(1):109-14. PubMed ID: 16874466
    [Abstract] [Full Text] [Related]

  • 31. Pathogen burden in degenerative aortic valves is associated with inflammatory and immune reactions.
    Skowasch D, Tuleta I, Steinmetz M, Pabst S, Preusse CJ, Welz A, Nickenig G, Bauriedel G.
    J Heart Valve Dis; 2009 Jul 11; 18(4):411-7. PubMed ID: 19852145
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Inflammation and Chlamydia pneumoniae infection correlate with the severity of peripheral arterial disease.
    Kaperonis EA, Liapis CD, Kakisis JD, Dimitroulis D, Papavassiliou VG, Perrea D, Kostakis AG.
    Eur J Vasc Endovasc Surg; 2006 May 11; 31(5):509-15. PubMed ID: 16427340
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis.
    Allison MA, Cheung P, Criqui MH, Langer RD, Wright CM.
    Circulation; 2006 Feb 14; 113(6):861-6. PubMed ID: 16461818
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.